IP Library › Patent Application 12433295
Patent Application Utility
App. No. 12/433,295 · Confirmation No. 8778

Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy

Abandoned -- Failure to Respond to an Office Action View Publication ↗
⬇ PDF
 Code Description Pages PDF
2010-10-01 ABN Abandonment 2 View
2010-01-22 CTRS Requirement for Restriction/Election 5 View
2009-12-17 NTC.PUB Notice of Publication 1 View
2009-09-09 APP.FILE.REC Filing Receipt 3 View
2009-08-31 WFEE Fee Worksheet (SB06) 2 View
2009-08-31 N417 Electronic Filing System Acknowledgment Receipt 2 View
2009-08-31 PEFR Applicant Response to Pre-Exam Formalities Notice 1 View
2009-08-31 OATH Oath or Declaration filed 3 View
2009-08-31 CLM Claims 1 View
2009-08-31 ABST Abstract 1 View
2009-08-31 TRAN.LET Transmittal Letter 1 View
2009-08-31 XT/ Extension of Time 2 View
2009-08-31 WFEE Fee Worksheet (SB06) 2 View
2009-08-31 N417 Electronic Filing System Acknowledgment Receipt 3 View
2009-08-31 SPEC Specification 31 View
2009-05-15 APP.FILE.REC Filing Receipt 3 View
2009-05-15 NTC.MISS.PRT Notice to File Missing Parts 2 View
2009-04-30 A.PE Preliminary Amendment 1 View
2009-04-30 SPEC Specification 1 View
2009-04-30 REM Applicant Arguments/Remarks Made in an Amendment 1 View
2009-04-30 N417 Electronic Filing System Acknowledgment Receipt 2 View
2009-04-30 SPEC Specification 20 View
2009-04-30 CLM Claims 1 View
2009-04-30 ABST Abstract 1 View
2009-04-30 ADS Application Data Sheet 5 View
2009-04-30 WFEE Fee Worksheet (SB06) 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
12/433,295
Filed
2009-04-30
Pub. No.
US20090311266A1
Art Unit
1644